Skip to main navigation Skip to search Skip to main content

A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus

Christopher Fawsitt*, Peter Vickerman, Graham S Cooke, Nicky Welton, STOP-HCV Consortium

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

11 Citations (Scopus)
80 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science